FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between GPT Healthcare IPO and JG Chemicals IPO.
GPT Healthcare IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while JG Chemicals IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
GPT Healthcare IPO | JG Chemicals IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Jm Financial Limited | Centrum Capital Limited Emkay Global Financial Services Ltd Keynote Financial Services Ltd |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of GPT Healthcare IPO is up to ₹525.14 Cr whereas the issue size of the JG Chemicals IPO is up to ₹251.19 Cr. The final issue price of GPT Healthcare IPO is ₹186.00 per share and of JG Chemicals IPO is ₹221.00 per share.
GPT Healthcare IPO | JG Chemicals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹177.00 per share | ₹210.00 per share |
Issue Price (Upper) | ₹186.00 per share | ₹221.00 per share |
Issue Price (Final) | ₹186.00 per share | ₹221.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 80 shares | 67 shares |
Fresh Issue Size | 21,50,537 shares | 74,66,063 shares |
Fresh Issue Size (Amount) | up to ₹40.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 2,60,82,786 shares | 39,00,000 shares |
OFS Issue Size (Amount) | up to ₹485.14 Cr | up to ₹86.19 Cr |
Issue Size Total | 2,82,33,323 shares | 1,13,66,063 shares |
Issue Size Total (Amount) | up to ₹525.14 Cr | up to ₹251.19 Cr |
GPT Healthcare IPO opens on Feb 22, 2024, while JG Chemicals IPO opens on Mar 05, 2024. The closing date of GPT Healthcare IPO and JG Chemicals IPO is Feb 26, 2024, and Mar 07, 2024, respectively.
GPT Healthcare IPO | JG Chemicals IPO | |
---|---|---|
Anchor Bid Date | Feb 21, 2024 | Mar 04, 2024 |
Issue Open | Feb 22, 2024 | Mar 05, 2024 |
Issue Close | Feb 26, 2024 | Mar 07, 2024 |
Basis Of Allotment (Tentative) | Feb 27, 2024 | Mar 11, 2024 |
Initiation of Refunds (Tentative) | Feb 28, 2024 | Mar 12, 2024 |
Credit of Share (Tentative) | Feb 28, 2024 | Mar 12, 2024 |
Listing date (Tentative) | Feb 29, 2024 | Mar 13, 2024 |
Anchor Lockin End date 1 | Mar 28, 2024 | Apr 10, 2024 |
Anchor Lockin End date 2 | May 27, 2024 | Jun 09, 2024 |
GPT Healthcare IPO P/E ratio is 38.1, as compared to JG Chemicals IPO P/E ratio of 16.25.
GPT Healthcare IPO | JG Chemicals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | GPT Healthcare Limited Financial Information (Restated Consolidated)GPT Healthcare Limited's revenue increased by 7.11% and profit after tax (PAT) dropped by -6.37% between the financial year ending with March 31, 2023 and March 31, 2022.
|
JG Chemicals Limited Financial Information (Restated Consolidated)JG Chemicals Limited's revenue increased by 27.47% and profit after tax (PAT) rose by 31.69% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 67.34% | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 38.1 | 16.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹1526.22 Cr. | ₹866.01 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 23.59%% | 8.20%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.09%% | 11.86 %% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.39 | 0.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.88 | ₹13.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 23.77%% | 8.16%% |
In the GPT Healthcare IPO retail investors (RII) are offered 98,81,663 shares while in JG Chemicals IPO retail investors are offered 98,81,663 shares. Qualified institutional buyers (QIB) are offered 56,46,665 shares in GPT Healthcare IPO and 22,73,214 shares in JG Chemicals IPO.
GPT Healthcare IPO | JG Chemicals IPO | |
---|---|---|
Anchor Investor Reserveration | 84,69,996 shares | 34,09,818 shares |
Market Maker Reserveration | ||
QIB | 56,46,665 shares | 22,73,214 shares |
NII | 42,34,999 shares | 17,04,910 shares |
RII | 98,81,663 shares | 39,78,122 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,97,63,327 shares | 79,56,246 shares |
GPT Healthcare IPO subscribed 8.52x in total, whereas JG Chemicals IPO subscribed 28.52x.
GPT Healthcare IPO | JG Chemicals IPO | |
---|---|---|
QIB (times) | 17.30x | 32.33x |
NII (times) | 11.02x | 47.92x |
Big NII (times) | 11.98x | 50.26x |
Small NII (times) | 9.09x | 43.24x |
RII (times) | 2.44x | 18.03x |
Employee (times) | ||
Other (times) | ||
Total (times) | 8.52x | 28.52x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|